Greenwich LifeSciences, Inc. (GLSI) stock

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 5/30

$14.94−0.34 (-2.23%)

Close on Nov 13, 2026Market cap $219.29MP/E –Yield –

Greenwich LifeSciences operating margin

Operating margin is operating income as a percentage of revenue.

Greenwich LifeSciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?